First Light Diagnostics Names New CEO
First Light Diagnostics, a developer of automated diagnostics for life-threatening antibiotic-resistant infections, has appointed Joanne Spadoro to serve as its new CEO.
Spadoro brings three decades of leadership experience at companies that include Roche Molecular Systems, Immucor and T2 Biosystems. She has led many devices from early development to commercialization, including the first commercial polymerase chain reaction products for infectious disease diagnosis, viral load monitoring and blood screening.
First Light aims to bring to market the first rapid tests that will enable clinicians to prescribe optimal antibiotics at the onset of infections.